Logo image of CRGO

FREIGHTOS LTD (CRGO) Stock Fundamental Analysis

USA - NASDAQ:CRGO - KYG514051013 - Common Stock

3.01 USD
-0.1 (-3.22%)
Last: 9/12/2025, 8:00:01 PM
3.01 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, CRGO scores 3 out of 10 in our fundamental rating. CRGO was compared to 23 industry peers in the Air Freight & Logistics industry. While CRGO seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, CRGO is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

CRGO had negative earnings in the past year.
CRGO had a negative operating cash flow in the past year.
CRGO had negative earnings in each of the past 5 years.
CRGO had a negative operating cash flow in each of the past 5 years.
CRGO Yearly Net Income VS EBIT VS OCF VS FCFCRGO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

With a Return On Assets value of -30.53%, CRGO is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
CRGO's Return On Equity of -43.41% is in line compared to the rest of the industry. CRGO outperforms 47.83% of its industry peers.
Industry RankSector Rank
ROA -30.53%
ROE -43.41%
ROIC N/A
ROA(3y)-54.74%
ROA(5y)-47.99%
ROE(3y)-81.96%
ROE(5y)-73.89%
ROIC(3y)N/A
ROIC(5y)N/A
CRGO Yearly ROA, ROE, ROICCRGO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

CRGO has a better Gross Margin (66.16%) than 91.30% of its industry peers.
In the last couple of years the Gross Margin of CRGO has grown nicely.
The Profit Margin and Operating Margin are not available for CRGO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.58%
GM growth 5YN/A
CRGO Yearly Profit, Operating, Gross MarginsCRGO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -100 -200 -300

5

2. Health

2.1 Basic Checks

CRGO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRGO has been increased compared to 1 year ago.
The debt/assets ratio for CRGO has been reduced compared to a year ago.
CRGO Yearly Shares OutstandingCRGO Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
CRGO Yearly Total Debt VS Total AssetsCRGO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CRGO has an Altman-Z score of 0.17. This is a bad value and indicates that CRGO is not financially healthy and even has some risk of bankruptcy.
CRGO's Altman-Z score of 0.17 is on the low side compared to the rest of the industry. CRGO is outperformed by 73.91% of its industry peers.
CRGO has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CRGO (0.02) is better than 78.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC7.85%
CRGO Yearly LT Debt VS Equity VS FCFCRGO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

CRGO has a Current Ratio of 2.35. This indicates that CRGO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.35, CRGO belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
CRGO has a Quick Ratio of 2.35. This indicates that CRGO is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CRGO (2.35) is better than 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
CRGO Yearly Current Assets VS Current LiabilitesCRGO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

CRGO shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.33%.
The Revenue has grown by 17.28% in the past year. This is quite good.
Measured over the past years, CRGO shows a very strong growth in Revenue. The Revenue has been growing by 28.84% on average per year.
EPS 1Y (TTM)-2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)17.28%
Revenue growth 3Y28.84%
Revenue growth 5YN/A
Sales Q2Q%31.46%

3.2 Future

CRGO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.36% yearly.
CRGO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 25.25% yearly.
EPS Next Y33.45%
EPS Next 2Y23.98%
EPS Next 3Y21.99%
EPS Next 5Y15.36%
Revenue Next Year25.74%
Revenue Next 2Y25.09%
Revenue Next 3Y25.71%
Revenue Next 5Y25.25%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CRGO Yearly Revenue VS EstimatesCRGO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 20M 40M 60M 80M 100M
CRGO Yearly EPS VS EstimatesCRGO Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -0.5 -1 -1.5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRGO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRGO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRGO Price Earnings VS Forward Price EarningsCRGO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CRGO Per share dataCRGO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as CRGO's earnings are expected to grow with 21.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.98%
EPS Next 3Y21.99%

0

5. Dividend

5.1 Amount

CRGO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

FREIGHTOS LTD

NASDAQ:CRGO (9/12/2025, 8:00:01 PM)

After market: 3.01 0 (0%)

3.01

-0.1 (-3.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)08-18 2025-08-18/bmo
Earnings (Next)11-25 2025-11-25/bmo
Inst Owners19.01%
Inst Owner Change3.48%
Ins Owners8.22%
Ins Owner ChangeN/A
Market Cap150.62M
Analysts84.44
Price Target4.76 (58.14%)
Short Float %0.04%
Short Ratio0.14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-53.05%
Min EPS beat(2)-117.86%
Max EPS beat(2)11.76%
EPS beat(4)2
Avg EPS beat(4)-12.68%
Min EPS beat(4)-117.86%
Max EPS beat(4)63.24%
EPS beat(8)5
Avg EPS beat(8)1.65%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.23%
Min Revenue beat(2)0%
Max Revenue beat(2)0.46%
Revenue beat(4)3
Avg Revenue beat(4)0.73%
Min Revenue beat(4)0%
Max Revenue beat(4)1.89%
Revenue beat(8)3
Avg Revenue beat(8)-0.25%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.7%
EPS NY rev (1m)3.16%
EPS NY rev (3m)8%
Revenue NQ rev (1m)-2.07%
Revenue NQ rev (3m)0.33%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.94
P/FCF N/A
P/OCF N/A
P/B 2.92
P/tB 5.37
EV/EBITDA N/A
EPS(TTM)-0.44
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.51
BVpS1.03
TBVpS0.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.53%
ROE -43.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.16%
FCFM N/A
ROA(3y)-54.74%
ROA(5y)-47.99%
ROE(3y)-81.96%
ROE(5y)-73.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.58%
GM growth 5YN/A
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.69%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 0.17
F-Score3
WACC7.85%
ROIC/WACCN/A
Cap/Depr(3y)4.93%
Cap/Depr(5y)7.18%
Cap/Sales(3y)0.64%
Cap/Sales(5y)0.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y33.45%
EPS Next 2Y23.98%
EPS Next 3Y21.99%
EPS Next 5Y15.36%
Revenue 1Y (TTM)17.28%
Revenue growth 3Y28.84%
Revenue growth 5YN/A
Sales Q2Q%31.46%
Revenue Next Year25.74%
Revenue Next 2Y25.09%
Revenue Next 3Y25.71%
Revenue Next 5Y25.25%
EBIT growth 1Y21.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year47.62%
EBIT Next 3Y25.87%
EBIT Next 5Y20.18%
FCF growth 1Y57.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.84%
OCF growth 3YN/A
OCF growth 5YN/A